Cargando…

Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients

PURPOSE: To develop a clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation (HSCT) recipients. METHODS: Recommendations were developed by an international multidisciplinary panel that included a patient advocate....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehrnbecher, Thomas, Fisher, Brian T., Phillips, Bob, Beauchemin, Melissa, Carlesse, Fabianne, Castagnola, Elio, Duong, Nathan, Dupuis, L. Lee, Fioravantti, Vicky, Groll, Andreas H., Haeusler, Gabrielle M., Roilides, Emmanuel, Science, Michelle, Steinbach, William J., Tissing, Wim, Warris, Adilia, Patel, Priya, Robinson, Paula D., Sung, Lillian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499615/ https://www.ncbi.nlm.nih.gov/pubmed/32459599 http://dx.doi.org/10.1200/JCO.20.00158

Ejemplares similares

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
por: Lehrnbecher, Thomas, et al.
Publicado: (2020)

Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study
por: Warris, Adilia, et al.
Publicado: (2020)

SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients()
por: Haeusler, Gabrielle M., et al.
Publicado: (2021)

Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Progress in the Diagnosis of Invasive Fungal Disease in Children
por: Warris, Adilia, et al.
Publicado: (2017)

Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children
por: King, Jill, et al.
Publicado: (2017)

Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality
por: Castagnola, Elio, et al.
Publicado: (2021)

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients
por: Diorio, Caroline, et al.
Publicado: (2018)

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis
por: Phillips, Robert S, et al.
Publicado: (2016)

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis
por: Phillips, Robert S, et al.
Publicado: (2016)

Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data
por: Ferreras-Antolin, Laura, et al.
Publicado: (2022)

The Role of Prophylaxis of Bacterial Infections in Children With Acute Leukemia/Non-Hodgkin Lymphoma
por: Castagnola, Elio
Publicado: (2014)

Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies
por: Stevenson, Emily M., et al.
Publicado: (2022)

Antifungal Activity of Antimicrobial Peptides and Proteins against Aspergillus fumigatus
por: Ballard, Eloise, et al.
Publicado: (2020)

Prophylaxis and Empirical Therapy of Infection in Cancer Patients
por: Castagnola, Elio, et al.
Publicado: (2015)

Antibiotic prophylaxis in acute childhood leukemia: What is known so far?
por: Dufrayer, Mauro Cesar, et al.
Publicado: (2023)

Prophylaxis of Invasive Fungal Infection in Neonates: A Narrative Review for Practical Purposes
por: Ferrando, Giulia, et al.
Publicado: (2023)

The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in Children
por: Warris, Adilia
Publicado: (2016)

Special Issue: Host–Fungus Interactions
por: Warris, Adilia
Publicado: (2018)

Candida auris, what do paediatricians need to know?
por: Warris, Adilia
Publicado: (2018)

Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
por: Warris, Adilia
Publicado: (2021)

Intro special issue MMCR session ISHAM
por: Warris, Adilia
Publicado: (2023)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

Antifungal Combination Therapy in Children with Cancer—A 4-Year Analysis of Real-Life Data of Two Major Pediatric Cancer Centers
por: Schöning, Stefan, et al.
Publicado: (2021)

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
por: Brunel, Shan F., et al.
Publicado: (2017)

Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children
por: Ferreras-Antolín, Laura, et al.
Publicado: (2021)

Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials
por: Egan, Grace, et al.
Publicado: (2019)

Editorial MMCR special issue ‘Covid-19 associated pulmonary aspergillosis’
por: Warris, Adilia, et al.
Publicado: (2021)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020)

Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials
por: Ethier, M C, et al.
Publicado: (2012)

Human metapneumovirus infection
por: Warris, Adilia, et al.
Publicado: (2007)

Paediatric Histoplasmosis 2000–2019: A Review of 83 Cases
por: MacInnes, Rebecca, et al.
Publicado: (2021)

Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

Aspergillosis in Chronic Granulomatous Disease
por: King, Jill, et al.
Publicado: (2016)

Unmasking a fungal fire
por: Dambuza, Ivy M., et al.
Publicado: (2023)

Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil
por: Dufrayer, Mauro Cesar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18cd3otb1su1cvda5uds8in31u